Global Brucellosis Vaccines Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Brucellosis Vaccines market size is predicted to grow from US$ 11.9 million in 2025 to US$ 15 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.
LP Information, Inc. (LPI) ' newest research report, the “Brucellosis Vaccines Industry Forecast” looks at past sales and reviews total world Brucellosis Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Brucellosis Vaccines sales for 2025 through 2031. With Brucellosis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brucellosis Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Brucellosis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Brucellosis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Brucellosis Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brucellosis Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brucellosis Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Brucellosis Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Brucellosis Vaccines market?
What factors are driving Brucellosis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Brucellosis Vaccines market opportunities vary by end market size?
How does Brucellosis Vaccines break out by Type, by Application?
The global Brucellosis Vaccines market size is predicted to grow from US$ 11.9 million in 2025 to US$ 15 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.
LP Information, Inc. (LPI) ' newest research report, the “Brucellosis Vaccines Industry Forecast” looks at past sales and reviews total world Brucellosis Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Brucellosis Vaccines sales for 2025 through 2031. With Brucellosis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brucellosis Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Brucellosis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Brucellosis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Brucellosis Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brucellosis Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brucellosis Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Brucellosis Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- S19 Vaccine
- RB51 Vaccine Strain
- Cattle
- Sheep
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jinyu
- Colorado Serum
- Boehringer Ingelheim
- Biogenesis-Bago
- Vetal Company
- CZ Veterinaria
- SYVA Laboratorios
- Indian Immunologicals
- Qilu
- Tecnovax
- Hester Biosciences
- Zoetis
- Onderstepoort Biological
- Instituto Rosenbusch
- Ceva Sante Animale
- Calier & Biologicos Laverlam
- Biovet
What is the 10-year outlook for the global Brucellosis Vaccines market?
What factors are driving Brucellosis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Brucellosis Vaccines market opportunities vary by end market size?
How does Brucellosis Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Brucellosis Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Brucellosis Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Brucellosis Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Brucellosis Vaccines Segment by Type
2.2.1 S19 Vaccine
2.2.2 RB51 Vaccine Strain
2.3 Brucellosis Vaccines Sales by Type
2.3.1 Global Brucellosis Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Brucellosis Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Brucellosis Vaccines Sale Price by Type (2020-2025)
2.4 Brucellosis Vaccines Segment by Application
2.4.1 Cattle
2.4.2 Sheep
2.4.3 Others
2.5 Brucellosis Vaccines Sales by Application
2.5.1 Global Brucellosis Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Brucellosis Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Brucellosis Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Brucellosis Vaccines Breakdown Data by Company
3.1.1 Global Brucellosis Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Brucellosis Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Brucellosis Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Brucellosis Vaccines Revenue by Company (2020-2025)
3.2.2 Global Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Brucellosis Vaccines Sale Price by Company
3.4 Key Manufacturers Brucellosis Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Brucellosis Vaccines Product Location Distribution
3.4.2 Players Brucellosis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BRUCELLOSIS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Brucellosis Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Brucellosis Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Brucellosis Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Brucellosis Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Brucellosis Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Brucellosis Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Brucellosis Vaccines Sales Growth
4.4 APAC Brucellosis Vaccines Sales Growth
4.5 Europe Brucellosis Vaccines Sales Growth
4.6 Middle East & Africa Brucellosis Vaccines Sales Growth
5 AMERICAS
5.1 Americas Brucellosis Vaccines Sales by Country
5.1.1 Americas Brucellosis Vaccines Sales by Country (2020-2025)
5.1.2 Americas Brucellosis Vaccines Revenue by Country (2020-2025)
5.2 Americas Brucellosis Vaccines Sales by Type (2020-2025)
5.3 Americas Brucellosis Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brucellosis Vaccines Sales by Region
6.1.1 APAC Brucellosis Vaccines Sales by Region (2020-2025)
6.1.2 APAC Brucellosis Vaccines Revenue by Region (2020-2025)
6.2 APAC Brucellosis Vaccines Sales by Type (2020-2025)
6.3 APAC Brucellosis Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Brucellosis Vaccines by Country
7.1.1 Europe Brucellosis Vaccines Sales by Country (2020-2025)
7.1.2 Europe Brucellosis Vaccines Revenue by Country (2020-2025)
7.2 Europe Brucellosis Vaccines Sales by Type (2020-2025)
7.3 Europe Brucellosis Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Brucellosis Vaccines by Country
8.1.1 Middle East & Africa Brucellosis Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Brucellosis Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Brucellosis Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Brucellosis Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Brucellosis Vaccines
10.3 Manufacturing Process Analysis of Brucellosis Vaccines
10.4 Industry Chain Structure of Brucellosis Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Brucellosis Vaccines Distributors
11.3 Brucellosis Vaccines Customer
12 WORLD FORECAST REVIEW FOR BRUCELLOSIS VACCINES BY GEOGRAPHIC REGION
12.1 Global Brucellosis Vaccines Market Size Forecast by Region
12.1.1 Global Brucellosis Vaccines Forecast by Region (2026-2031)
12.1.2 Global Brucellosis Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Brucellosis Vaccines Forecast by Type (2026-2031)
12.7 Global Brucellosis Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Jinyu
13.1.1 Jinyu Company Information
13.1.2 Jinyu Brucellosis Vaccines Product Portfolios and Specifications
13.1.3 Jinyu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Jinyu Main Business Overview
13.1.5 Jinyu Latest Developments
13.2 Colorado Serum
13.2.1 Colorado Serum Company Information
13.2.2 Colorado Serum Brucellosis Vaccines Product Portfolios and Specifications
13.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Colorado Serum Main Business Overview
13.2.5 Colorado Serum Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Brucellosis Vaccines Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Biogenesis-Bago
13.4.1 Biogenesis-Bago Company Information
13.4.2 Biogenesis-Bago Brucellosis Vaccines Product Portfolios and Specifications
13.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Biogenesis-Bago Main Business Overview
13.4.5 Biogenesis-Bago Latest Developments
13.5 Vetal Company
13.5.1 Vetal Company Company Information
13.5.2 Vetal Company Brucellosis Vaccines Product Portfolios and Specifications
13.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Vetal Company Main Business Overview
13.5.5 Vetal Company Latest Developments
13.6 CZ Veterinaria
13.6.1 CZ Veterinaria Company Information
13.6.2 CZ Veterinaria Brucellosis Vaccines Product Portfolios and Specifications
13.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CZ Veterinaria Main Business Overview
13.6.5 CZ Veterinaria Latest Developments
13.7 SYVA Laboratorios
13.7.1 SYVA Laboratorios Company Information
13.7.2 SYVA Laboratorios Brucellosis Vaccines Product Portfolios and Specifications
13.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 SYVA Laboratorios Main Business Overview
13.7.5 SYVA Laboratorios Latest Developments
13.8 Indian Immunologicals
13.8.1 Indian Immunologicals Company Information
13.8.2 Indian Immunologicals Brucellosis Vaccines Product Portfolios and Specifications
13.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Indian Immunologicals Main Business Overview
13.8.5 Indian Immunologicals Latest Developments
13.9 Qilu
13.9.1 Qilu Company Information
13.9.2 Qilu Brucellosis Vaccines Product Portfolios and Specifications
13.9.3 Qilu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Qilu Main Business Overview
13.9.5 Qilu Latest Developments
13.10 Tecnovax
13.10.1 Tecnovax Company Information
13.10.2 Tecnovax Brucellosis Vaccines Product Portfolios and Specifications
13.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tecnovax Main Business Overview
13.10.5 Tecnovax Latest Developments
13.11 Hester Biosciences
13.11.1 Hester Biosciences Company Information
13.11.2 Hester Biosciences Brucellosis Vaccines Product Portfolios and Specifications
13.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hester Biosciences Main Business Overview
13.11.5 Hester Biosciences Latest Developments
13.12 Zoetis
13.12.1 Zoetis Company Information
13.12.2 Zoetis Brucellosis Vaccines Product Portfolios and Specifications
13.12.3 Zoetis Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Zoetis Main Business Overview
13.12.5 Zoetis Latest Developments
13.13 Onderstepoort Biological
13.13.1 Onderstepoort Biological Company Information
13.13.2 Onderstepoort Biological Brucellosis Vaccines Product Portfolios and Specifications
13.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Onderstepoort Biological Main Business Overview
13.13.5 Onderstepoort Biological Latest Developments
13.14 Instituto Rosenbusch
13.14.1 Instituto Rosenbusch Company Information
13.14.2 Instituto Rosenbusch Brucellosis Vaccines Product Portfolios and Specifications
13.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Instituto Rosenbusch Main Business Overview
13.14.5 Instituto Rosenbusch Latest Developments
13.15 Ceva Sante Animale
13.15.1 Ceva Sante Animale Company Information
13.15.2 Ceva Sante Animale Brucellosis Vaccines Product Portfolios and Specifications
13.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Ceva Sante Animale Main Business Overview
13.15.5 Ceva Sante Animale Latest Developments
13.16 Calier & Biologicos Laverlam
13.16.1 Calier & Biologicos Laverlam Company Information
13.16.2 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolios and Specifications
13.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Calier & Biologicos Laverlam Main Business Overview
13.16.5 Calier & Biologicos Laverlam Latest Developments
13.17 Biovet
13.17.1 Biovet Company Information
13.17.2 Biovet Brucellosis Vaccines Product Portfolios and Specifications
13.17.3 Biovet Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Biovet Main Business Overview
13.17.5 Biovet Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Brucellosis Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Brucellosis Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Brucellosis Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Brucellosis Vaccines Segment by Type
2.2.1 S19 Vaccine
2.2.2 RB51 Vaccine Strain
2.3 Brucellosis Vaccines Sales by Type
2.3.1 Global Brucellosis Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Brucellosis Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Brucellosis Vaccines Sale Price by Type (2020-2025)
2.4 Brucellosis Vaccines Segment by Application
2.4.1 Cattle
2.4.2 Sheep
2.4.3 Others
2.5 Brucellosis Vaccines Sales by Application
2.5.1 Global Brucellosis Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Brucellosis Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Brucellosis Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Brucellosis Vaccines Breakdown Data by Company
3.1.1 Global Brucellosis Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Brucellosis Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Brucellosis Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Brucellosis Vaccines Revenue by Company (2020-2025)
3.2.2 Global Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Brucellosis Vaccines Sale Price by Company
3.4 Key Manufacturers Brucellosis Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Brucellosis Vaccines Product Location Distribution
3.4.2 Players Brucellosis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BRUCELLOSIS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Brucellosis Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Brucellosis Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Brucellosis Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Brucellosis Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Brucellosis Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Brucellosis Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Brucellosis Vaccines Sales Growth
4.4 APAC Brucellosis Vaccines Sales Growth
4.5 Europe Brucellosis Vaccines Sales Growth
4.6 Middle East & Africa Brucellosis Vaccines Sales Growth
5 AMERICAS
5.1 Americas Brucellosis Vaccines Sales by Country
5.1.1 Americas Brucellosis Vaccines Sales by Country (2020-2025)
5.1.2 Americas Brucellosis Vaccines Revenue by Country (2020-2025)
5.2 Americas Brucellosis Vaccines Sales by Type (2020-2025)
5.3 Americas Brucellosis Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brucellosis Vaccines Sales by Region
6.1.1 APAC Brucellosis Vaccines Sales by Region (2020-2025)
6.1.2 APAC Brucellosis Vaccines Revenue by Region (2020-2025)
6.2 APAC Brucellosis Vaccines Sales by Type (2020-2025)
6.3 APAC Brucellosis Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Brucellosis Vaccines by Country
7.1.1 Europe Brucellosis Vaccines Sales by Country (2020-2025)
7.1.2 Europe Brucellosis Vaccines Revenue by Country (2020-2025)
7.2 Europe Brucellosis Vaccines Sales by Type (2020-2025)
7.3 Europe Brucellosis Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Brucellosis Vaccines by Country
8.1.1 Middle East & Africa Brucellosis Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Brucellosis Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Brucellosis Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Brucellosis Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Brucellosis Vaccines
10.3 Manufacturing Process Analysis of Brucellosis Vaccines
10.4 Industry Chain Structure of Brucellosis Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Brucellosis Vaccines Distributors
11.3 Brucellosis Vaccines Customer
12 WORLD FORECAST REVIEW FOR BRUCELLOSIS VACCINES BY GEOGRAPHIC REGION
12.1 Global Brucellosis Vaccines Market Size Forecast by Region
12.1.1 Global Brucellosis Vaccines Forecast by Region (2026-2031)
12.1.2 Global Brucellosis Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Brucellosis Vaccines Forecast by Type (2026-2031)
12.7 Global Brucellosis Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Jinyu
13.1.1 Jinyu Company Information
13.1.2 Jinyu Brucellosis Vaccines Product Portfolios and Specifications
13.1.3 Jinyu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Jinyu Main Business Overview
13.1.5 Jinyu Latest Developments
13.2 Colorado Serum
13.2.1 Colorado Serum Company Information
13.2.2 Colorado Serum Brucellosis Vaccines Product Portfolios and Specifications
13.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Colorado Serum Main Business Overview
13.2.5 Colorado Serum Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Brucellosis Vaccines Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Biogenesis-Bago
13.4.1 Biogenesis-Bago Company Information
13.4.2 Biogenesis-Bago Brucellosis Vaccines Product Portfolios and Specifications
13.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Biogenesis-Bago Main Business Overview
13.4.5 Biogenesis-Bago Latest Developments
13.5 Vetal Company
13.5.1 Vetal Company Company Information
13.5.2 Vetal Company Brucellosis Vaccines Product Portfolios and Specifications
13.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Vetal Company Main Business Overview
13.5.5 Vetal Company Latest Developments
13.6 CZ Veterinaria
13.6.1 CZ Veterinaria Company Information
13.6.2 CZ Veterinaria Brucellosis Vaccines Product Portfolios and Specifications
13.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CZ Veterinaria Main Business Overview
13.6.5 CZ Veterinaria Latest Developments
13.7 SYVA Laboratorios
13.7.1 SYVA Laboratorios Company Information
13.7.2 SYVA Laboratorios Brucellosis Vaccines Product Portfolios and Specifications
13.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 SYVA Laboratorios Main Business Overview
13.7.5 SYVA Laboratorios Latest Developments
13.8 Indian Immunologicals
13.8.1 Indian Immunologicals Company Information
13.8.2 Indian Immunologicals Brucellosis Vaccines Product Portfolios and Specifications
13.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Indian Immunologicals Main Business Overview
13.8.5 Indian Immunologicals Latest Developments
13.9 Qilu
13.9.1 Qilu Company Information
13.9.2 Qilu Brucellosis Vaccines Product Portfolios and Specifications
13.9.3 Qilu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Qilu Main Business Overview
13.9.5 Qilu Latest Developments
13.10 Tecnovax
13.10.1 Tecnovax Company Information
13.10.2 Tecnovax Brucellosis Vaccines Product Portfolios and Specifications
13.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tecnovax Main Business Overview
13.10.5 Tecnovax Latest Developments
13.11 Hester Biosciences
13.11.1 Hester Biosciences Company Information
13.11.2 Hester Biosciences Brucellosis Vaccines Product Portfolios and Specifications
13.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hester Biosciences Main Business Overview
13.11.5 Hester Biosciences Latest Developments
13.12 Zoetis
13.12.1 Zoetis Company Information
13.12.2 Zoetis Brucellosis Vaccines Product Portfolios and Specifications
13.12.3 Zoetis Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Zoetis Main Business Overview
13.12.5 Zoetis Latest Developments
13.13 Onderstepoort Biological
13.13.1 Onderstepoort Biological Company Information
13.13.2 Onderstepoort Biological Brucellosis Vaccines Product Portfolios and Specifications
13.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Onderstepoort Biological Main Business Overview
13.13.5 Onderstepoort Biological Latest Developments
13.14 Instituto Rosenbusch
13.14.1 Instituto Rosenbusch Company Information
13.14.2 Instituto Rosenbusch Brucellosis Vaccines Product Portfolios and Specifications
13.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Instituto Rosenbusch Main Business Overview
13.14.5 Instituto Rosenbusch Latest Developments
13.15 Ceva Sante Animale
13.15.1 Ceva Sante Animale Company Information
13.15.2 Ceva Sante Animale Brucellosis Vaccines Product Portfolios and Specifications
13.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Ceva Sante Animale Main Business Overview
13.15.5 Ceva Sante Animale Latest Developments
13.16 Calier & Biologicos Laverlam
13.16.1 Calier & Biologicos Laverlam Company Information
13.16.2 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolios and Specifications
13.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Calier & Biologicos Laverlam Main Business Overview
13.16.5 Calier & Biologicos Laverlam Latest Developments
13.17 Biovet
13.17.1 Biovet Company Information
13.17.2 Biovet Brucellosis Vaccines Product Portfolios and Specifications
13.17.3 Biovet Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Biovet Main Business Overview
13.17.5 Biovet Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Brucellosis Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Brucellosis Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of S19 Vaccine
Table 4. Major Players of RB51 Vaccine Strain
Table 5. Global Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 6. Global Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Table 7. Global Brucellosis Vaccines Revenue by Type (2020-2025) & ($ million)
Table 8. Global Brucellosis Vaccines Revenue Market Share by Type (2020-2025)
Table 9. Global Brucellosis Vaccines Sale Price by Type (2020-2025) & (USD/K Doses)
Table 10. Global Brucellosis Vaccines Sale by Application (2020-2025) & (M Doses)
Table 11. Global Brucellosis Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Brucellosis Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Brucellosis Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Brucellosis Vaccines Sale Price by Application (2020-2025) & (USD/K Doses)
Table 15. Global Brucellosis Vaccines Sales by Company (2020-2025) & (M Doses)
Table 16. Global Brucellosis Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Brucellosis Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Brucellosis Vaccines Sale Price by Company (2020-2025) & (USD/K Doses)
Table 20. Key Manufacturers Brucellosis Vaccines Producing Area Distribution and Sales Area
Table 21. Players Brucellosis Vaccines Products Offered
Table 22. Brucellosis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Brucellosis Vaccines Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global Brucellosis Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Brucellosis Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Brucellosis Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Brucellosis Vaccines Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global Brucellosis Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Brucellosis Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Brucellosis Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Brucellosis Vaccines Sales by Country (2020-2025) & (M Doses)
Table 34. Americas Brucellosis Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Brucellosis Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 37. Americas Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 38. APAC Brucellosis Vaccines Sales by Region (2020-2025) & (M Doses)
Table 39. APAC Brucellosis Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Brucellosis Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 42. APAC Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 43. Europe Brucellosis Vaccines Sales by Country (2020-2025) & (M Doses)
Table 44. Europe Brucellosis Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 46. Europe Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa Brucellosis Vaccines Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa Brucellosis Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 50. Middle East & Africa Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Brucellosis Vaccines
Table 52. Key Market Challenges & Risks of Brucellosis Vaccines
Table 53. Key Industry Trends of Brucellosis Vaccines
Table 54. Brucellosis Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Brucellosis Vaccines Distributors List
Table 57. Brucellosis Vaccines Customer List
Table 58. Global Brucellosis Vaccines Sales Forecast by Region (2026-2031) & (M Doses)
Table 59. Global Brucellosis Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Brucellosis Vaccines Sales Forecast by Country (2026-2031) & (M Doses)
Table 61. Americas Brucellosis Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Brucellosis Vaccines Sales Forecast by Region (2026-2031) & (M Doses)
Table 63. APAC Brucellosis Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Brucellosis Vaccines Sales Forecast by Country (2026-2031) & (M Doses)
Table 65. Europe Brucellosis Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Brucellosis Vaccines Sales Forecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa Brucellosis Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Brucellosis Vaccines Sales Forecast by Type (2026-2031) & (M Doses)
Table 69. Global Brucellosis Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Brucellosis Vaccines Sales Forecast by Application (2026-2031) & (M Doses)
Table 71. Global Brucellosis Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Jinyu Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Jinyu Brucellosis Vaccines Product Portfolios and Specifications
Table 74. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 75. Jinyu Main Business
Table 76. Jinyu Latest Developments
Table 77. Colorado Serum Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Colorado Serum Brucellosis Vaccines Product Portfolios and Specifications
Table 79. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. Colorado Serum Main Business
Table 81. Colorado Serum Latest Developments
Table 82. Boehringer Ingelheim Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Boehringer Ingelheim Brucellosis Vaccines Product Portfolios and Specifications
Table 84. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 85. Boehringer Ingelheim Main Business
Table 86. Boehringer Ingelheim Latest Developments
Table 87. Biogenesis-Bago Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Biogenesis-Bago Brucellosis Vaccines Product Portfolios and Specifications
Table 89. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 90. Biogenesis-Bago Main Business
Table 91. Biogenesis-Bago Latest Developments
Table 92. Vetal Company Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Vetal Company Brucellosis Vaccines Product Portfolios and Specifications
Table 94. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 95. Vetal Company Main Business
Table 96. Vetal Company Latest Developments
Table 97. CZ Veterinaria Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. CZ Veterinaria Brucellosis Vaccines Product Portfolios and Specifications
Table 99. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 100. CZ Veterinaria Main Business
Table 101. CZ Veterinaria Latest Developments
Table 102. SYVA Laboratorios Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. SYVA Laboratorios Brucellosis Vaccines Product Portfolios and Specifications
Table 104. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 105. SYVA Laboratorios Main Business
Table 106. SYVA Laboratorios Latest Developments
Table 107. Indian Immunologicals Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Indian Immunologicals Brucellosis Vaccines Product Portfolios and Specifications
Table 109. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 110. Indian Immunologicals Main Business
Table 111. Indian Immunologicals Latest Developments
Table 112. Qilu Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Qilu Brucellosis Vaccines Product Portfolios and Specifications
Table 114. Qilu Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 115. Qilu Main Business
Table 116. Qilu Latest Developments
Table 117. Tecnovax Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Tecnovax Brucellosis Vaccines Product Portfolios and Specifications
Table 119. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. Tecnovax Main Business
Table 121. Tecnovax Latest Developments
Table 122. Hester Biosciences Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Hester Biosciences Brucellosis Vaccines Product Portfolios and Specifications
Table 124. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 125. Hester Biosciences Main Business
Table 126. Hester Biosciences Latest Developments
Table 127. Zoetis Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Zoetis Brucellosis Vaccines Product Portfolios and Specifications
Table 129. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 130. Zoetis Main Business
Table 131. Zoetis Latest Developments
Table 132. Onderstepoort Biological Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Onderstepoort Biological Brucellosis Vaccines Product Portfolios and Specifications
Table 134. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 135. Onderstepoort Biological Main Business
Table 136. Onderstepoort Biological Latest Developments
Table 137. Instituto Rosenbusch Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. Instituto Rosenbusch Brucellosis Vaccines Product Portfolios and Specifications
Table 139. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 140. Instituto Rosenbusch Main Business
Table 141. Instituto Rosenbusch Latest Developments
Table 142. Ceva Sante Animale Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. Ceva Sante Animale Brucellosis Vaccines Product Portfolios and Specifications
Table 144. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 145. Ceva Sante Animale Main Business
Table 146. Ceva Sante Animale Latest Developments
Table 147. Calier & Biologicos Laverlam Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolios and Specifications
Table 149. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 150. Calier & Biologicos Laverlam Main Business
Table 151. Calier & Biologicos Laverlam Latest Developments
Table 152. Biovet Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. Biovet Brucellosis Vaccines Product Portfolios and Specifications
Table 154. Biovet Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 155. Biovet Main Business
Table 156. Biovet Latest Developments
Table 1. Brucellosis Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Brucellosis Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of S19 Vaccine
Table 4. Major Players of RB51 Vaccine Strain
Table 5. Global Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 6. Global Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Table 7. Global Brucellosis Vaccines Revenue by Type (2020-2025) & ($ million)
Table 8. Global Brucellosis Vaccines Revenue Market Share by Type (2020-2025)
Table 9. Global Brucellosis Vaccines Sale Price by Type (2020-2025) & (USD/K Doses)
Table 10. Global Brucellosis Vaccines Sale by Application (2020-2025) & (M Doses)
Table 11. Global Brucellosis Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Brucellosis Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Brucellosis Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Brucellosis Vaccines Sale Price by Application (2020-2025) & (USD/K Doses)
Table 15. Global Brucellosis Vaccines Sales by Company (2020-2025) & (M Doses)
Table 16. Global Brucellosis Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Brucellosis Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Brucellosis Vaccines Sale Price by Company (2020-2025) & (USD/K Doses)
Table 20. Key Manufacturers Brucellosis Vaccines Producing Area Distribution and Sales Area
Table 21. Players Brucellosis Vaccines Products Offered
Table 22. Brucellosis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Brucellosis Vaccines Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global Brucellosis Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Brucellosis Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Brucellosis Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Brucellosis Vaccines Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global Brucellosis Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Brucellosis Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Brucellosis Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Brucellosis Vaccines Sales by Country (2020-2025) & (M Doses)
Table 34. Americas Brucellosis Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Brucellosis Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 37. Americas Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 38. APAC Brucellosis Vaccines Sales by Region (2020-2025) & (M Doses)
Table 39. APAC Brucellosis Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Brucellosis Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 42. APAC Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 43. Europe Brucellosis Vaccines Sales by Country (2020-2025) & (M Doses)
Table 44. Europe Brucellosis Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 46. Europe Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa Brucellosis Vaccines Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa Brucellosis Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 50. Middle East & Africa Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Brucellosis Vaccines
Table 52. Key Market Challenges & Risks of Brucellosis Vaccines
Table 53. Key Industry Trends of Brucellosis Vaccines
Table 54. Brucellosis Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Brucellosis Vaccines Distributors List
Table 57. Brucellosis Vaccines Customer List
Table 58. Global Brucellosis Vaccines Sales Forecast by Region (2026-2031) & (M Doses)
Table 59. Global Brucellosis Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Brucellosis Vaccines Sales Forecast by Country (2026-2031) & (M Doses)
Table 61. Americas Brucellosis Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Brucellosis Vaccines Sales Forecast by Region (2026-2031) & (M Doses)
Table 63. APAC Brucellosis Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Brucellosis Vaccines Sales Forecast by Country (2026-2031) & (M Doses)
Table 65. Europe Brucellosis Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Brucellosis Vaccines Sales Forecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa Brucellosis Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Brucellosis Vaccines Sales Forecast by Type (2026-2031) & (M Doses)
Table 69. Global Brucellosis Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Brucellosis Vaccines Sales Forecast by Application (2026-2031) & (M Doses)
Table 71. Global Brucellosis Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Jinyu Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Jinyu Brucellosis Vaccines Product Portfolios and Specifications
Table 74. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 75. Jinyu Main Business
Table 76. Jinyu Latest Developments
Table 77. Colorado Serum Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Colorado Serum Brucellosis Vaccines Product Portfolios and Specifications
Table 79. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. Colorado Serum Main Business
Table 81. Colorado Serum Latest Developments
Table 82. Boehringer Ingelheim Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Boehringer Ingelheim Brucellosis Vaccines Product Portfolios and Specifications
Table 84. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 85. Boehringer Ingelheim Main Business
Table 86. Boehringer Ingelheim Latest Developments
Table 87. Biogenesis-Bago Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Biogenesis-Bago Brucellosis Vaccines Product Portfolios and Specifications
Table 89. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 90. Biogenesis-Bago Main Business
Table 91. Biogenesis-Bago Latest Developments
Table 92. Vetal Company Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Vetal Company Brucellosis Vaccines Product Portfolios and Specifications
Table 94. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 95. Vetal Company Main Business
Table 96. Vetal Company Latest Developments
Table 97. CZ Veterinaria Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. CZ Veterinaria Brucellosis Vaccines Product Portfolios and Specifications
Table 99. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 100. CZ Veterinaria Main Business
Table 101. CZ Veterinaria Latest Developments
Table 102. SYVA Laboratorios Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. SYVA Laboratorios Brucellosis Vaccines Product Portfolios and Specifications
Table 104. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 105. SYVA Laboratorios Main Business
Table 106. SYVA Laboratorios Latest Developments
Table 107. Indian Immunologicals Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Indian Immunologicals Brucellosis Vaccines Product Portfolios and Specifications
Table 109. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 110. Indian Immunologicals Main Business
Table 111. Indian Immunologicals Latest Developments
Table 112. Qilu Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Qilu Brucellosis Vaccines Product Portfolios and Specifications
Table 114. Qilu Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 115. Qilu Main Business
Table 116. Qilu Latest Developments
Table 117. Tecnovax Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Tecnovax Brucellosis Vaccines Product Portfolios and Specifications
Table 119. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. Tecnovax Main Business
Table 121. Tecnovax Latest Developments
Table 122. Hester Biosciences Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Hester Biosciences Brucellosis Vaccines Product Portfolios and Specifications
Table 124. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 125. Hester Biosciences Main Business
Table 126. Hester Biosciences Latest Developments
Table 127. Zoetis Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Zoetis Brucellosis Vaccines Product Portfolios and Specifications
Table 129. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 130. Zoetis Main Business
Table 131. Zoetis Latest Developments
Table 132. Onderstepoort Biological Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Onderstepoort Biological Brucellosis Vaccines Product Portfolios and Specifications
Table 134. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 135. Onderstepoort Biological Main Business
Table 136. Onderstepoort Biological Latest Developments
Table 137. Instituto Rosenbusch Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. Instituto Rosenbusch Brucellosis Vaccines Product Portfolios and Specifications
Table 139. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 140. Instituto Rosenbusch Main Business
Table 141. Instituto Rosenbusch Latest Developments
Table 142. Ceva Sante Animale Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. Ceva Sante Animale Brucellosis Vaccines Product Portfolios and Specifications
Table 144. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 145. Ceva Sante Animale Main Business
Table 146. Ceva Sante Animale Latest Developments
Table 147. Calier & Biologicos Laverlam Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolios and Specifications
Table 149. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 150. Calier & Biologicos Laverlam Main Business
Table 151. Calier & Biologicos Laverlam Latest Developments
Table 152. Biovet Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. Biovet Brucellosis Vaccines Product Portfolios and Specifications
Table 154. Biovet Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 155. Biovet Main Business
Table 156. Biovet Latest Developments
LIST OF FIGURES
Figure 1. Picture of Brucellosis Vaccines
Figure 2. Brucellosis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brucellosis Vaccines Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Brucellosis Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Brucellosis Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Brucellosis Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Brucellosis Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of S19 Vaccine
Figure 12. Product Picture of RB51 Vaccine Strain
Figure 13. Global Brucellosis Vaccines Sales Market Share by Type in 2025
Figure 14. Global Brucellosis Vaccines Revenue Market Share by Type (2020-2025)
Figure 15. Brucellosis Vaccines Consumed in Cattle
Figure 16. Global Brucellosis Vaccines Market: Cattle (2020-2025) & (M Doses)
Figure 17. Brucellosis Vaccines Consumed in Sheep
Figure 18. Global Brucellosis Vaccines Market: Sheep (2020-2025) & (M Doses)
Figure 19. Brucellosis Vaccines Consumed in Others
Figure 20. Global Brucellosis Vaccines Market: Others (2020-2025) & (M Doses)
Figure 21. Global Brucellosis Vaccines Sale Market Share by Application (2024)
Figure 22. Global Brucellosis Vaccines Revenue Market Share by Application in 2025
Figure 23. Brucellosis Vaccines Sales by Company in 2025 (M Doses)
Figure 24. Global Brucellosis Vaccines Sales Market Share by Company in 2025
Figure 25. Brucellosis Vaccines Revenue by Company in 2025 ($ millions)
Figure 26. Global Brucellosis Vaccines Revenue Market Share by Company in 2025
Figure 27. Global Brucellosis Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Brucellosis Vaccines Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Brucellosis Vaccines Sales 2020-2025 (M Doses)
Figure 30. Americas Brucellosis Vaccines Revenue 2020-2025 ($ millions)
Figure 31. APAC Brucellosis Vaccines Sales 2020-2025 (M Doses)
Figure 32. APAC Brucellosis Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Europe Brucellosis Vaccines Sales 2020-2025 (M Doses)
Figure 34. Europe Brucellosis Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Brucellosis Vaccines Sales 2020-2025 (M Doses)
Figure 36. Middle East & Africa Brucellosis Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Americas Brucellosis Vaccines Sales Market Share by Country in 2025
Figure 38. Americas Brucellosis Vaccines Revenue Market Share by Country (2020-2025)
Figure 39. Americas Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Figure 40. Americas Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Figure 41. United States Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Brucellosis Vaccines Sales Market Share by Region in 2025
Figure 46. APAC Brucellosis Vaccines Revenue Market Share by Region (2020-2025)
Figure 47. APAC Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Figure 48. APAC Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Figure 49. China Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. India Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Brucellosis Vaccines Sales Market Share by Country in 2025
Figure 57. Europe Brucellosis Vaccines Revenue Market Share by Country (2020-2025)
Figure 58. Europe Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Figure 59. Europe Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Germany Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. France Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Brucellosis Vaccines Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Figure 68. Egypt Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Brucellosis Vaccines in 2025
Figure 74. Manufacturing Process Analysis of Brucellosis Vaccines
Figure 75. Industry Chain Structure of Brucellosis Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Brucellosis Vaccines Sales Market Forecast by Region (2026-2031)
Figure 78. Global Brucellosis Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Brucellosis Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Brucellosis Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Brucellosis Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Brucellosis Vaccines Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Brucellosis Vaccines
Figure 2. Brucellosis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brucellosis Vaccines Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Brucellosis Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Brucellosis Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Brucellosis Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Brucellosis Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of S19 Vaccine
Figure 12. Product Picture of RB51 Vaccine Strain
Figure 13. Global Brucellosis Vaccines Sales Market Share by Type in 2025
Figure 14. Global Brucellosis Vaccines Revenue Market Share by Type (2020-2025)
Figure 15. Brucellosis Vaccines Consumed in Cattle
Figure 16. Global Brucellosis Vaccines Market: Cattle (2020-2025) & (M Doses)
Figure 17. Brucellosis Vaccines Consumed in Sheep
Figure 18. Global Brucellosis Vaccines Market: Sheep (2020-2025) & (M Doses)
Figure 19. Brucellosis Vaccines Consumed in Others
Figure 20. Global Brucellosis Vaccines Market: Others (2020-2025) & (M Doses)
Figure 21. Global Brucellosis Vaccines Sale Market Share by Application (2024)
Figure 22. Global Brucellosis Vaccines Revenue Market Share by Application in 2025
Figure 23. Brucellosis Vaccines Sales by Company in 2025 (M Doses)
Figure 24. Global Brucellosis Vaccines Sales Market Share by Company in 2025
Figure 25. Brucellosis Vaccines Revenue by Company in 2025 ($ millions)
Figure 26. Global Brucellosis Vaccines Revenue Market Share by Company in 2025
Figure 27. Global Brucellosis Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Brucellosis Vaccines Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Brucellosis Vaccines Sales 2020-2025 (M Doses)
Figure 30. Americas Brucellosis Vaccines Revenue 2020-2025 ($ millions)
Figure 31. APAC Brucellosis Vaccines Sales 2020-2025 (M Doses)
Figure 32. APAC Brucellosis Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Europe Brucellosis Vaccines Sales 2020-2025 (M Doses)
Figure 34. Europe Brucellosis Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Brucellosis Vaccines Sales 2020-2025 (M Doses)
Figure 36. Middle East & Africa Brucellosis Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Americas Brucellosis Vaccines Sales Market Share by Country in 2025
Figure 38. Americas Brucellosis Vaccines Revenue Market Share by Country (2020-2025)
Figure 39. Americas Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Figure 40. Americas Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Figure 41. United States Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Brucellosis Vaccines Sales Market Share by Region in 2025
Figure 46. APAC Brucellosis Vaccines Revenue Market Share by Region (2020-2025)
Figure 47. APAC Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Figure 48. APAC Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Figure 49. China Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. India Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Brucellosis Vaccines Sales Market Share by Country in 2025
Figure 57. Europe Brucellosis Vaccines Revenue Market Share by Country (2020-2025)
Figure 58. Europe Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Figure 59. Europe Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Germany Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. France Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Brucellosis Vaccines Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Figure 68. Egypt Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Brucellosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Brucellosis Vaccines in 2025
Figure 74. Manufacturing Process Analysis of Brucellosis Vaccines
Figure 75. Industry Chain Structure of Brucellosis Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Brucellosis Vaccines Sales Market Forecast by Region (2026-2031)
Figure 78. Global Brucellosis Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Brucellosis Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Brucellosis Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Brucellosis Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Brucellosis Vaccines Revenue Market Share Forecast by Application (2026-2031)
